European Commission Regulation 37/2010 of 22 December 2009. on pharmacologically active substances and their classification” is an important and relevant work created by a team of authors, which immerses the reader in the world of legislation relating to the pharmacology and safety of medicines. This publication will be especially useful for specialists in the field of medicine, pharmaceuticals, as well as for students and researchers interested in the regulation of pharmacological substances. The book examines in detail the key aspects of the regulation, which was an important step in ensuring the safety and effectiveness of medicines in the European Union. The authors not only analyze the text of the regulation itself, but also explain its significance in the context of modern pharmacology, raising questions about the classification of active substances and their impact on human health. This makes the book an indispensable source of information for those who work in the field of drug development and quality control. The topics covered in the book cover a wide range of issues related to pharmacological safety. Readers will be able to learn about the principles of classification of active substances, how regulations affect the development of new drugs, as well as the mechanisms that protect public health. The book also raises important questions about the interaction between research and legislative initiatives, making it relevant for professionals seeking to understand the complex processes taking place in the field of pharmaceuticals. This work will be a real find for those who are interested in the legal aspects of pharmacology. It can attract the attention of not only specialists, but also students of medical and pharmaceutical universities who want to understand more deeply how pharmacologically active substances are regulated in Europe. The book will also be useful to lawyers working in the field of health, and anyone interested in the safety of drugs and their impact on public health. The style of the authors is characterized by clarity and accessibility of presentation, which allows the reader to easily assimilate complex concepts and terms. They use examples and illustrations to make the material more understandable and visual. The book "Regulation of the European Commission 37/2010" not only sets out the facts, but also offers an analytical approach to understanding the legislation, which makes it interesting for discussion at scientific conferences and seminars. If you are looking for literature that will help you understand the intricacies of pharmacological regulation, this book will be an excellent choice. It will not only expand your knowledge, but also help you better understand how laws and regulations affect the development of medicine and pharmaceutics in the modern world. Thus, the “Regulation of the European Commission 37/2010” is not just a collection of regulations, but an in-depth analysis and study that will help readers see the importance and need for strict control in the field of pharmacology. This book will be a reliable companion for all who seek to be aware of current issues and trends in the field of health and pharmaceuticals.